68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

Summary

Patients with primary intermediate risk prostate cancer for whom radical prostatectomy is indicated, will be invited to participate to the present study. Positron Emission Tomography coupled with scanner (PET-CT) using a radiotracer : 68Ga-RM2 and Positron Emission Tomography coupled with scanner (PET-CT) using another radiotracer : 68Ga-PSMA-617, will be scheduled.

Timeline

Start

2019-07-11

Primary completion

2023-06-15

Completion

2023-07-11

Outcome

Outcome not reported

Stopped: “target number of patients not reached”

Publications

• Perozziello F, Robert G, Meyer M, Jambon E, Bladou F, Yacoub M, Lamare F, Vimont D, Balamoutoff N, Hindie E, Morgat C. Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer. Eur J Nucl Med Mol Imaging. 2026 Jun;53(7):4386-4394. doi: 10.1007/s00259-026-07780-y. Epub 2026 Feb 9.

Drugs

Indications